Piperoxan (hydrochloride) |
An α2-AR antagonist (Kis = 5.4, 2, and 1.3 nM for α2A-, &alpha… |
5 mg |
27629-5 |
More Info
|
Piperoxan (hydrochloride) |
An α2-AR antagonist (Kis = 5.4, 2, and 1.3 nM for α2A-, &alpha… |
50 mg |
27629-50 |
More Info
|
Pipradrol (hydrochloride) |
An analytical reference standard categorized as a stimulant; regulated as… |
10 mg |
14783-10 |
More Info
|
Pipradrol (hydrochloride) |
An analytical reference standard categorized as a stimulant; regulated as… |
5 mg |
14783-5 |
More Info
|
Pipradrol (hydrochloride) |
An analytical reference standard categorized as a stimulant; regulated as… |
50 mg |
14783-50 |
More Info
|
PiPT |
An analytical reference standard categorized as a tryptamine; intended for… |
1 mg |
33953-1 |
More Info
|
PiPT |
An analytical reference standard categorized as a tryptamine; intended for… |
5 mg |
33953-5 |
More Info
|
Piracetam |
A nootropic drug that has efficacy in stroke rehabilitation in animal mode… |
10 g |
20755-10 |
More Info
|
Piracetam |
A nootropic drug that has efficacy in stroke rehabilitation in animal mode… |
25 g |
20755-25 |
More Info
|
Piracetam |
A nootropic drug that has efficacy in stroke rehabilitation in animal mode… |
5 g |
20755-5 |
More Info
|
Piracetam-d6 |
An internal standard for the quantification of piracetam by GC- or LC-MS |
1 mg |
34241-1 |
More Info
|
Piracetam-d6 |
An internal standard for the quantification of piracetam by GC- or LC-MS |
5 mg |
34241-5 |
More Info
|
Piracetam-d6 |
An internal standard for the quantification of piracetam by GC- or LC-MS |
500 µg |
34241-500 |
More Info
|
Pirarubicin |
An anthracycline with anticancer activity; interacts with topoisomerase II… |
10 mg |
28384-10 |
More Info
|
Pirarubicin |
An anthracycline with anticancer activity; interacts with topoisomerase II… |
100 mg |
28384-100 |
More Info
|
Pirarubicin |
An anthracycline with anticancer activity; interacts with topoisomerase II… |
25 mg |
28384-25 |
More Info
|
Pirarubicin |
An anthracycline with anticancer activity; interacts with topoisomerase II… |
5 mg |
28384-5 |
More Info
|
Pirenzepine (hydrochloride) |
A muscarinic M1 receptor antagonist (Ki = 11.48 nM); selective for M1 over… |
1 g |
29527-1 |
More Info
|
Pirenzepine (hydrochloride) |
A muscarinic M1 receptor antagonist (Ki = 11.48 nM); selective for M1 over… |
5 g |
29527-5 |
More Info
|
Pirenzepine (hydrochloride) |
A muscarinic M1 receptor antagonist (Ki = 11.48 nM); selective for M1 over… |
500 mg |
29527-500 |
More Info
|
Pirfenidone |
An orally bioavailable pyridone derivative with antifibrotic, anti-inflamm… |
10 mg |
13986-10 |
More Info
|
Pirfenidone |
An orally bioavailable pyridone derivative with antifibrotic, anti-inflamm… |
100 mg |
13986-100 |
More Info
|
Pirfenidone |
An orally bioavailable pyridone derivative with antifibrotic, anti-inflamm… |
5 mg |
13986-5 |
More Info
|
Pirfenidone |
An orally bioavailable pyridone derivative with antifibrotic, anti-inflamm… |
50 mg |
13986-50 |
More Info
|
Pirfenidone-d5 |
An internal standard for the quantification of pirfenidone by GC- or LC-MS |
1 mg |
26452-1 |
More Info
|
Pirfenidone-d5 |
An internal standard for the quantification of pirfenidone by GC- or LC-MS |
500 µg |
26452-500 |
More Info
|
Piribedil |
A dopamine receptor agonist; binds to dopamine D2, D3, and D4 receptors (I… |
1 g |
30321-1 |
More Info
|
Piribedil |
A dopamine receptor agonist; binds to dopamine D2, D3, and D4 receptors (I… |
100 mg |
30321-100 |
More Info
|
Piribedil |
A dopamine receptor agonist; binds to dopamine D2, D3, and D4 receptors (I… |
250 mg |
30321-250 |
More Info
|
Piribedil |
A dopamine receptor agonist; binds to dopamine D2, D3, and D4 receptors (I… |
500 mg |
30321-500 |
More Info
|
Piribedil N-oxide |
A metabolite of piribedil |
1 mg |
36328-1 |
More Info
|
Piribedil N-oxide |
A metabolite of piribedil |
10 mg |
36328-10 |
More Info
|
Piribedil N-oxide |
A metabolite of piribedil |
25 mg |
36328-25 |
More Info
|
Piribedil N-oxide |
A metabolite of piribedil |
5 mg |
36328-5 |
More Info
|
Pirinixic Acid Aminothiazole |
A dual inhibitor of mPGES-1 and 5-LO (IC50s = 0.4 and 0.2 µM, respec… |
1 mg |
15483-1 |
More Info
|
Pirinixic Acid Aminothiazole |
A dual inhibitor of mPGES-1 and 5-LO (IC50s = 0.4 and 0.2 µM, respec… |
10 mg |
15483-10 |
More Info
|
Pirinixic Acid Aminothiazole |
A dual inhibitor of mPGES-1 and 5-LO (IC50s = 0.4 and 0.2 µM, respec… |
25 mg |
15483-25 |
More Info
|
Pirinixic Acid Aminothiazole |
A dual inhibitor of mPGES-1 and 5-LO (IC50s = 0.4 and 0.2 µM, respec… |
5 mg |
15483-5 |
More Info
|
Piriprost (potassium salt) |
Piriprost is a structural analog of PGI2 with low IP receptor-mediated act… |
1 mg |
18228-1 |
More Info
|
Piriprost (potassium salt) |
Piriprost is a structural analog of PGI2 with low IP receptor-mediated act… |
10 mg |
18228-10 |
More Info
|
Piriprost (potassium salt) |
Piriprost is a structural analog of PGI2 with low IP receptor-mediated act… |
5 mg |
18228-5 |
More Info
|
Piriprost (potassium salt) |
Piriprost is a structural analog of PGI2 with low IP receptor-mediated act… |
50 mg |
18228-50 |
More Info
|
Pirlimycin |
A lincosamide antibiotic effective against Gram-positive bacteria that act… |
1 mg |
20138-1 |
More Info
|
Pirlimycin |
A lincosamide antibiotic effective against Gram-positive bacteria that act… |
5 mg |
20138-5 |
More Info
|
Pirlindole |
A selective and reversible MAO-A inhibitor (IC50s = 250 and 34.2 nM for ra… |
10 mg |
22060-10 |
More Info
|
Pirlindole |
A selective and reversible MAO-A inhibitor (IC50s = 250 and 34.2 nM for ra… |
25 mg |
22060-25 |
More Info
|
Pirlindole |
A selective and reversible MAO-A inhibitor (IC50s = 250 and 34.2 nM for ra… |
5 mg |
22060-5 |
More Info
|
Pirlindole |
A selective and reversible MAO-A inhibitor (IC50s = 250 and 34.2 nM for ra… |
50 mg |
22060-50 |
More Info
|
Pirlindole-d4 (hydrochloride) |
An internal standard for the quantification of pirlindole by GC- or LC-MS |
1 mg |
33375-1 |
More Info
|
Pirlindole-d4 (hydrochloride) |
An internal standard for the quantification of pirlindole by GC- or LC-MS |
500 µg |
33375-500 |
More Info
|